B
Vertex Pharmaceuticals Incorporated VRTX
$395.12 -$2.34-0.59% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue 2.94B 2.76B 2.91B 2.77B 2.65B
Total Other Revenue 20.70M 10.00M -- -- --
Total Revenue 2.96B 2.77B 2.91B 2.77B 2.65B
Cost of Revenue 507.10M 1.34B 1.26B 1.27B 469.00M
Gross Profit 2.46B 1.43B 1.65B 1.50B 2.18B
SG&A Expenses 424.60M 396.40M 345.00M 371.80M 372.20M
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 1.81B 1.74B 1.60B 1.64B 1.71B
Operating Income 1.15B 1.03B 1.31B 1.13B 934.90M
Income Before Tax 1.28B 730.40M 1.14B 1.22B -3.39B
Income Tax Expenses 250.10M 84.10M 223.50M 178.70M 202.40M
Earnings from Continuing Operations 1.03B 646.30M 913.00M 1.05B -3.59B
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 1.03B 646.30M 913.00M 1.05B -3.59B
EBIT 1.15B 1.03B 1.31B 1.13B 934.90M
EBITDA 1.21B 1.08B 1.33B 1.18B 988.90M
EPS Basic 4.02 2.52 3.55 4.05 -13.92
Normalized Basic EPS 3.12 2.79 3.44 3.00 2.59
EPS Diluted 3.99 2.49 3.50 4.01 -13.92
Normalized Diluted EPS 3.09 2.76 3.40 2.96 2.59
Average Basic Shares Outstanding 256.70M 256.90M 257.50M 258.00M 258.10M
Average Diluted Shares Outstanding 258.90M 259.50M 260.50M 261.00M 258.10M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --